Unknown PHASE4 INTERVENTIONAL 2-arm NCT03215407

The Comparative Study of Intra-articular Injection of Tocilizumab and Compound Betamethasone

The Comparative Study of Safety and Effectiveness of Intra-articular Injection of Tocilizumab and Compound Betamethasone in Rheumatoid Arthritis of the Knee

Sponsor: Chinese PLA General Hospital

Conditions Rheumatoid Arthritis of Knee

Interventions Intra-articular Compound Betamethasone Intra-articular Tocilizumab

Updated 6 times since 2017 Last updated: Jul 12, 2017 Started: Aug 1, 2017 Primary completion: Dec 12, 2017 Completion: Mar 3, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Rheumatoid Arthritis of Knee, this trial is ongoing. The trial is conducted by Chinese PLA General Hospital and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Aug 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Aug 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese PLA General Hospital

Data source: Chinese PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.